Top-Paying Oncology Specialties Worldwide in 2025

Top-Paying

SIOG and OncoDaily Announce Strategic Partnership to Advance Global Geriatric Oncology

SIOG

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology

Minhua Chu: Rui Therapeutics Completed a Series A Financing Exceeding RMB 200 Million

Minhua Chu, Rui Therapeutics

Applications are Open for IDEA Program with Special QI Mentorship Opportunity - ASCO

IDEA Program

Anirban Maitra: Encorafenib, Cetuximab, and Nivolumab in Microsatellite Stable BRAFV600E mCRC

Anirban Maitra

Razelle Kurzrock: Our Commentary and Implications for Future Precision Studies

Razelle Kurzrock

Perioperative Nivolumab ± Ipilimumab in Resectable Diffuse Pleural Mesothelioma

Perioperative Nivolumab ± Ipilimumab in Resectable Diffuse Pleural Mesothelioma

OncoCalendar

Loading Events

« All Events

  • This event has passed.

The Nordic Radiotherapy Diploma Programme (NORTHDIP) for Clinical Oncologists by ESTRO

March 1 • 12:00 AM - March 5 • 12:00 AM
ESTRO Webinar Series

The Nordic Radiotherapy Diploma Programme (NORTHDIP) for Clinical Oncologists by ESTRO will be going on for two years from March 2025 to November 2026.

The Nordic Radiotherapy Diploma Programme (NORTHDIP) is a two-year advanced education initiative designed for clinical oncologists across the Nordic countries: Denmark, Iceland, Finland, Norway, and Sweden. The programme addresses the need for supplementary radiotherapy training for oncologists who specialize in radiotherapy after their clinical oncology education.

The goal of NORTHDIP is to enhance radiotherapy skills and foster collaboration among Nordic clinical oncologists, ultimately advancing expertise in the region and promoting collaborative research and development in radiotherapy.

The programme’s content is aligned with ESTRO’s core curriculum for radiation oncologists and covers a variety of advanced topics:

  • Sweden 2024: Advanced radiophysics, dose planning, organs-at-risk constraints, and advanced technologies.
  • Norway 2025: Radiobiology, benign diseases, and palliative care.
  • Finland 2025: Reirradiation, stereotactic radiotherapy, and BNCT (Boron Neutron Capture Therapy).
  • Denmark 2026: Adaptive radiotherapy and imaging (CBCT, dual-energy CT, PET-CT, MRI), including the integration of proton and MR-Linac therapy.
  • Iceland 2026: Nordic research protocols, including the design of clinical trials for collaborative Nordic implementation and shared patient recruitment.